Obsidian, Galera to advance cell therapy following reverse merger [Yahoo! Finance]
GALERA THERAPEUTICS INC (GRTX)
Company Research
Source: Yahoo! Finance
Obsidian Therapeutics, a private biotechnology company, will begin trading on the Nasdaq following a reverse merger with Galera Therapeutics announced Tuesday. The combined company will focus on developing Obsidian's main asset, a cell therapy codenamed OBX-115. The medicine is created using white blood cells known as tumor infiltrating lymphocytes, or TILs, that are harvested from the patient, engineered to better fight cancer and then reinfused. In 2024, Iovance Biotherapeutics' Amtagvi became the first TIL cell therapy approved by the Food and Drug Administration. OBX-115 is currently in human testing, where researchers are evaluating it in a mid-stage trial for advanced melanoma and an early-stage study for non-small cell lung cancer. The therapy, according to Obsidian, is designed to be durable as well as easier on the patient in several ways. For example, it doesn't require patients to take “interleukin-2” drugs, which are highly toxic but often useful for supporting the tr
Show less
Read more
Impact Snapshot
Event Time:
GRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRTX alerts
High impacting GALERA THERAPEUTICS INC news events
Weekly update
A roundup of the hottest topics
GRTX
News
- GRTX Stock Alert: Halper Sadeh LLC is Investigating Whether Galera Therapeutics, Inc. is Obtaining a Fair Price for its ShareholdersBusiness Wire
- Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private PlacementGlobeNewswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Galera Therapeutics, Inc. (OTCMKTS: GRTX) GlobeNewswire
- Obsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private PlacementBusiness Wire
GRTX
Sec Filings
- 4/15/26 - Form 425
- 4/14/26 - Form 425
- 4/14/26 - Form 425
- GRTX's page on the SEC website